Sanofi - Company Profile

Powered by

All the data and insights you need on Sanofi in one report.

  • Save hours of research time and resources with
    our up-to-date Sanofi Strategy Report

  • Understand Sanofi position in the market,
    performance and strategic initiatives.

  • Gain competitive edge and increase your
    chances of success

Sanofi is a healthcare company, which is engaged in the discovery, development, manufacturing, and marketing of a wide range of medicines and vaccines. Its portfolio includes medicines for the treatment of cancer, rare diseases, multiple sclerosis; human vaccines for protection against various bacterial and viral diseases; and other products. The company also offers consumer healthcare products for digestion; allergy; cough, cold, flu and sinus; pain; women’s health; and vitamins, minerals, and supplements. Sanofi's R&D efforts focus on advancing a combination drug to increase the effectiveness of treatments and on advancing the formulation of new biologics to produce precision medicines. It has operations in Europe, the Americas, Asia-Pacific, Africa, and the Middle East. Sanofi is headquartered in Paris, Ile-de-France, France.

Gain a 360-degree view of Sanofi and make more informed decisions for your business Gain a 360-degree view of Sanofi and make more informed decisions for your business Find out more
Headquarters France

Address 46 Avenue De La Grande Armee, Paris, Ile-de-France, 75017


Telephone 33 1 53774000

No of Employees 87,994

Industry Pharmaceuticals and Healthcare

Ticker Symbol & Exchange SAN (EPA)

Revenue (2022) $50.2B 2.3% (2022 vs 2021)

EPS XYZ

Net Income (2022) XYZ -35.5% (2022 vs 2021)

Market Cap* $117.6B

Net Profit Margin (2022) XYZ -36.9% (2022 vs 2021)

* As of and is in US$
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Find out more

Sanofi premium industry data and analytics

4,200+

Clinical Trials

Determine Sanofi go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

1,400+

Lead Sheet

Understand when and why to target accounts of prospective leads, as well as who to reach out to, drawing on intelligence for Sanofi’s relevant decision makers and contact details.

1,400+

Catalyst Calendar

Proactively evaluate Sanofi’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

1,000+

Marketed Drugs

Understand Sanofi’s commercialized product portfolio to stay one step ahead of the market.

750+

Pipeline Drugs

Identify which of Sanofi’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

480+

Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

110+

Regulatory Milestones

Track drug and patent expiries along with geographies impacted.

80+

Sales & Consensus Forecasts

Understand the current and future drug revenue for Sanofi and assess market opportunity for new entrants with patient population 8-year forecasts.

4

Investigators

Review investigator profiles and find information on trial contacts across Sanofi, including performance indicators like number of completed trials, and linked attributes such as rehiring statistics.

11+

IT Services Contracts

Improve competitive bidding with insights into all publicly disclosed IT services contracts for Sanofi (including IT outsourcing, business process outsourcing, systems integration & consulting and more).

1

ICT Spend & Tech Priorities

IT Client Prospector provides intelligence on Sanofi’s likely spend across technology areas enabling you to understand the digital strategy.

Products and Services

Products Brands
- Dupixent
Specialty Care: Aubagio
Atopic Dermatitis Lemtrada
XYZ XYZ
XYZ XYZ
XYZ XYZ
Understand Sanofi portfolio and identify potential areas for collaboration Understand Sanofi portfolio and identify potential areas for collaboration Find out more

History

History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.

Year Event Description
2024 Plans/Strategy In April, the company announced its plans to introduce 1 or 2 products every year from its innovation portfolio in India.
2024 Contracts/Agreements In April, Opella Healthcare entered into a partnership with Phoenix to distribute the OTC products.
2024 New Products/Services In April, the company launched Verorab in the UK.
Dive into past operations, including product releases, deals, acquisitions & more Dive into past operations, including product releases, deals, acquisitions & more Find out more
Image for loader

Competitor Comparison

Key Parameters Sanofi Johnson & Johnson F. Hoffmann-La Roche Ltd Merck & Co Inc Pfizer Inc
Headquarters France United States of America Switzerland United States of America United States of America
City Paris New Brunswick Basel Kenilworth New York
State/Province Ile-de-France New Jersey - New Jersey New York
No. of Employees 87,994 131,900 103,605 72,000 88,000
Entity Type Public Public Public Public Public
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Find out more
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Find out more
Executives
Name Position Board Since Age
Paul Hudson Chief Executive Officer; Director Executive Board 2019 55
Jean-Baptiste Chasseloup de Chatillon Chief Financial Officer; Executive Vice President Senior Management 2018 58
Natalie Bickford Chief People Officer; Executive Vice President Senior Management 2020 53
Emmanuel Frenehard Chief Digital Officer Senior Management 2023 -
Frederic Oudea Chairman Non Executive Board 2023 -
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Gain insight into Sanofi key executives to enhance your sales strategy Gain insight into Sanofi key executives to enhance your sales strategy Find out more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward